Are T-helper and regulatory T-cell levels higher in CABG patients compared to aortic valve surgery patients?
What the Evidence Shows
What we've found so far suggests that T-helper and regulatory T-cell levels may be higher in patients undergoing coronary artery bypass grafting (CABG) compared to those having aortic valve surgery. Our analysis of the available evidence currently leans in this direction.
We reviewed one claim from the research, and it indicates that people undergoing heart bypass surgery show higher levels of certain immune cells—such as T-helper and regulatory T-cells—in their heart fluid and blood than those undergoing heart valve surgery . This pattern was observed across 27 supporting analyses, with no studies or claims found that contradict it . These immune cells play key roles in managing inflammation and immune responses, so their increased presence could reflect differences in how the body responds to the underlying heart condition or the surgical procedure itself.
However, we base this on a limited number of claims so far—just one distinct finding, even if supported by multiple analyses. We don’t yet know how consistent this difference is across different patient groups, timing of measurements, or testing methods. Also, we can’t determine from the current evidence whether the surgery type causes the difference or if it’s related to the disease state before surgery.
Our current analysis shows a consistent signal in the data, but we need more studies that directly compare these two patient groups to strengthen our understanding. Immune responses vary widely between individuals, and many factors—like age, overall health, and specific surgical techniques—could influence these levels.
Practical takeaway: If you're having heart surgery, your immune response might depend partly on the type of procedure and your underlying condition—but we don’t yet have enough detail to predict or change care based on this alone.